Year-over-year, this metric grew by 5950.0%, from $4.00M to $242.00M. Over 3 years (FY 2021 to FY 2025), Other Income (Expense) shows a downward trend with a -21.5% CAGR.
An increase suggests higher non-operating gains or lower non-operating costs, while a decrease indicates higher non-operating expenses or lower non-operating income.
Represents the net total of non-operating financial activities, including interest income, interest expense, foreign cur...
Standard across all public companies; peers in the medical device sector often show similar volatility due to currency fluctuations.
other_income_expense_net| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $3.00M | $2.00M | $302.00M | $13.00M | $1.00M | $5.00M | $69.00M | $0.00 | $1.00M | $1.00M | $0.00 | $0.00 | $1.00M | -$1.00M | $4.00M | $22.00M | $122.00M | $0.00 | $242.00M |
| QoQ Change | — | -33.3% | >999% | -95.7% | -92.3% | +400.0% | >999% | -100.0% | — | +0.0% | -100.0% | — | — | -200.0% | +500.0% | +450.0% | +454.5% | -100.0% | — |
| YoY Change | — | — | — | — | -66.7% | +150.0% | +430.8% | -100.0% | -80.0% | — | -100.0% | — | +0.0% | -200.0% | — | — | >999% | +100.0% | >999% |